Jack Nathan Health Announces Graduation to Tier 1 Status on the TSX Venture Exchange
14 Mai 2021 - 1:00PM
Business Wire
Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF)
(“Jack Nathan Health” “JNH'' or the “Company”) is pleased to
announce that it has been approved for graduation to Tier 1 Issuer
status from Tier 2 Issuer status by the TSX Venture Exchange (the
"TSXV"), effective May 19, 2021.
“Our graduation to a Tier 1 listing is yet another milestone for
us and a signal to the market of how far we have come since our
qualifying transaction in October 2020,” said George Barakat,
Chairman and Chief Executive Officer of Jack Nathan Health. “As we
accelerate our operational growth plans this year it is important
for us to remain committed to ensuring our visibility as a publicly
traded company continues to enhance. We believe this upgrade will
provide us with greater access to investors and generate additional
awareness.”
The TSXV classifies issuers into different tiers based on
certain standards including historical financial performance, stage
of development and financial resources. Tier 1 is the TSXV's
premier tier and is reserved for the TSXV's most advanced issuers
with the most significant financial resources. With the graduation
to a Tier 1 listing on the TSXV, the securities of Jack Nathan
Health previously deposited into escrow will now be governed by the
release provisions of issuers subject to Tier 1 status and released
over 18 months (1).
About Jack Nathan Medical Corp.
Jack Nathan Medical Corp., operating as Jack Nathan Health®, is
one of Canada’s largest healthcare networks. Jack Nathan Health® is
an innovative healthcare company that is improving access for
millions of patients by co-locating physician and ancillary medical
services conveniently located inside Walmart® stores.
Jack Nathan Health® provides an exceptional level of patient
care, made possible through patient-centric physicians, a variety
of medical services, technology, and programs, designed to put
patients first. Our mission is to provide everyone access to the
finest quality retail medical centres, with both in-clinic
physicians and digital telemedicine, so you and your loved ones can
“Live Your Best Life”.
Jack Nathan Health® was established in 2006 and continues to
expand its international footprint, delivering exceptional,
state-of-the-art, turn-key medical centres in 76 Walmart locations
across Canada including British Columbia, Alberta, Saskatchewan,
Manitoba, Ontario, and Quebec, as well as 18 locations operating in
Mexico and 50 new locations opening in 2021.
For more information, visit www.jacknathanhealth.com or
www.sedar.com.
- 15,000,000 will be immediately releasable; 15,000,000 common
shares will be releasable on October 6, 2021; and 15,000,000
common shares will be releasable on April 6, 2022.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as defined in policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Certain statements contained in this press release constitute
"forward-looking information" as such term is defined in applicable
Canadian securities legislation. The words "may", "would", "could",
"should", "potential", "will", "seek", "intend", "plan",
"anticipate", "believe", "estimate", "expect" and similar
expressions as they relate to Jack Nathan are intended to identify
forward-looking information. All statements other than statements
of historical fact may be forward-looking information. Such
statements reflect the Company's current views and intentions with
respect to future events, and current information available to
them, and are subject to certain risks, uncertainties, and
assumptions Many factors could cause the actual results,
performance or achievements that may be expressed or implied by
such forward-looking information to vary from those described
herein should one or more of these risks or uncertainties
materialize. Such factors include but are not limited to: changes
in economic conditions or financial markets; increases in costs;
litigation; legislative and other judicial, regulatory, political
and competitive developments; the economic and business impact of
COVID-19 and operational difficulties. This list is not exhaustive
of the factors that may affect forward-looking information. These
and other factors should be considered carefully, and readers
should not place undue reliance on such forward-looking
information. Should any factor affect the Company in an unexpected
manner, or should assumptions underlying the forward-looking
information prove incorrect, the actual results or events may
differ materially from the results or events predicted. Any such
forward-looking information is expressly qualified in its entirety
by this cautionary statement. Moreover, the Company does not assume
responsibility for the accuracy or completeness of such
forward-looking information. The forward-looking information
included in this press release is made as of the date of this press
release and the Company undertakes no obligation to publicly update
or revise any forward-looking information, other than as required
by applicable law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210514005138/en/
IR: Prit Singh, Thesis Capital psingh@thesiscapital.ca
David Berman, CFO, david.berman@jacknathanhealth.com
Media: Crystal Quast, Bullseye Corporate
quast@bullseyecorporate.com
Jack Nathan Medical (TSXV:JNH)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
Jack Nathan Medical (TSXV:JNH)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024